NeuroPace, Inc. expected to post a loss of 21 cents a share - Earnings Preview

NeuroPace

07/08/2026 21:45

NeuroPace, Inc. NPCE.OQ NPCE.O is expected to  show a fall in quarterly revenue when it reports  results on August 10 (estimated) for the period ending June 30 2026
The Mountain View California-based  company is expected to report a 3.7% decrease in revenue to $22.654 million from $23.52 million a year ago, according to the mean estimate from 9 analysts, based on LSEG data.
​LSEG's mean analyst estimate for NeuroPace, Inc. is for a loss of 21 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for NeuroPace, Inc. is $20.00, about 43.9% above its last closing price of $13.90
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.22
-0.23
-0.20
Beat
13
Dec. 31 2026
-0.14
-0.15
-0.08
Beat
47.2
Sep. 30 2025
-0.19
-0.20
-0.11
Beat
43.9​
Jun. 30 2025
-0.22
-0.22
-0.26
Missed
-16.9
​​Mar. 31 2025
-0.24
-0.24
-0.21
Beat
13
Dec. 31 2024
-0.22
-0.22
-0.18
Beat
19.2​
Sep. 30 2024
-0.27
-0.27
-0.19
Beat
29.2
Jun. 30 2024
-0.30
-0.30
-0.26
Beat
13.3
This summary was machine generated August 7 at 20:45 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)